Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE3C4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,788
Award facts
- Contract value 100% obligated
- $82,787.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $82,787.67 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 27, 2025. This firm fixed price delivery order, which is not set-aside designated, is scheduled for completion by August 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic immunosuppressant medication commonly used to treat conditions such as atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical devices to support Defense Health Agency operations and other government healthcare systems. The competitively awarded delivery order reflects the company's established capability to fulfill specialized pharmaceutical requirements within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FE3C4?
SPE2DB25FE3C4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FE3C4 worth?
The government has obligated $82,788 on SPE2DB25FE3C4.
Is contract SPE2DB25FE3C4 an order under another contract?
Yes. SPE2DB25FE3C4 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3C4 competed?
The extent of competition for SPE2DB25FE3C4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award